Your browser doesn't support javascript.
loading
MEK Is a Therapeutic and Chemopreventative Target in Squamous Cell Carcinoma.
Adelmann, Charles H; Truong, Kimberly A; Liang, Roger J; Bansal, Varun; Gandee, Leah; Saporito, Rachael C; Lee, Woojin; Du, Lili; Nicholas, Courtney; Napoli, Marco; Mino, Barbara; South, Andrew P; Proby, Charlotte M; Leigh, Irene M; Coarfa, Cristian; Flores, Elsa R; Tsai, Kenneth Y.
Afiliação
  • Adelmann CH; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Truong KA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Liang RJ; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bansal V; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gandee L; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Saporito RC; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lee W; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Du L; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Nicholas C; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Napoli M; Department of Molecular & Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mino B; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • South AP; Department of Dermatology, Jefferson University, Philadelphia, Pennsylvania, USA.
  • Proby CM; Centre Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland.
  • Leigh IM; Jacqui Wood Cancer Centre, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland.
  • Coarfa C; Department of Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.
  • Flores ER; Department of Molecular & Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tsai KY; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: kytsai@mdanderson.org.
J Invest Dermatol ; 136(9): 1920-1924, 2016 09.
Article em En | MEDLINE | ID: mdl-27293029
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Proteínas Quinases Ativadas por Mitógeno / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Proteínas Quinases Ativadas por Mitógeno / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: J Invest Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos